Beurer India Pvt Ltd launches GL 22 Blood Glucose Monitor, ET HealthWorld

New Delhi: Beurer India Pvt Ltd has officially launched the GL 22 Blood Glucose Monitor, unveiled by cricket legend and brand ambassador Sourav Ganguly.

The GL 22 Blood Glucose Monitor, manufactured under the brand’s ‘Make in India’ initiative, combines German precision with advanced technology designed to meet local needs. The device features comprehensive monitoring capabilities, including average readings for 7, 14, 30, and 90 days, offering crucial insights into blood glucose trends. These features closely align with HbA1c levels, a critical marker for long-term blood sugar control, ensuring users and healthcare providers can manage diabetes more effectively.

Speaking at the event, Ganguly expressed, “Promoting a healthy lifestyle is something I deeply value, and I am proud to be associated with Beurer India. The GL 22 Monitor empowers individuals to take control of their health, perfectly aligning with Beurer’s vision of making quality healthcare accessible to all.”

Sebastian Kebbe, COO and MD, Beurer GmbH, said, “By manufacturing under the ‘Make in India’ initiative, we’ve ensured the product is tailored to the needs of Indian consumers, combining world-class quality with affordability.”

Salil VS, Managing Director and CEO, Beurer India, added, “With Sourav Ganguly’s support, we aim to create greater awareness about diabetes management and empower users to take proactive steps for their health. Our expansion strategy includes robust online and offline distribution networks, ensuring the GL 22 and our other products are easily accessible to consumers nationwide.”

• Published On Nov 27, 2024 at 02:01 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

• Get Realtime updates
• Save your favourite articles

Scan to download App